Stephen Brannan, MD

Dr Brannan is chief medical officer at Karuna Therapeutics and a neuroscience drug development expert.

March 10, 2021

Video

Data published in The New England Journal of Medicine shows promise for a novel schizophrenia treatment.

December 23, 2020

Video

Hear details from the phase II trial of xanomeline-trospium and how it assists in the treatment of acute schizophrenia.